SPL
IMVT icon

Superior Planning, LLC’s Immunovant IMVT Stock Holding History

Superior Planning, LLC’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$979 Buy
+29
New +$1.14K ﹤0.01% 1755

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Superior Planning, LLC's IMVT Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Immunovant (IMVT) in Q3 2026: 29 shares worth $979. The stake represents ﹤0.01% of the portfolio and ranks #1755 among its holdings.

123 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Superior Planning, LLC held 29 shares of Immunovant worth $979 as of Q3 2026.
  • Immunovant was a new Superior Planning, LLC position in Q3 2026.
  • Immunovant made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1755 holding.
  • 123 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.